Review
doi: 10.1177/003591577707001214.
The evidence justifying immunosuppression therapy in multiple sclerosis
- PMID: 202967
- PMCID: PMC1543529
- DOI: 10.1177/003591577707001214
Item in Clipboard
Review
The evidence justifying immunosuppression therapy in multiple sclerosis
Proc R Soc Med.
1977 Dec.
No abstract available
Similar articles
-
[Use of antilymphocyte globulin in autoimmune nervous system diseases].Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(1):53-64. Folia Haematol Int Mag Klin Morphol Blutforsch. 1979. PMID: 88390 Review. German.
-
[Immunological aspects in multiple sclerosis. I. Lymphocyte subpopulations and antilymphocyte antibodies].Rev Paul Med. 1987 May-Jun;105(3):134-40. Rev Paul Med. 1987. PMID: 3502426 Portuguese. No abstract available.
-
[Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].Postepy Hig Med Dosw. 1978 Jul-Aug;32(4):513-22. Postepy Hig Med Dosw. 1978. PMID: 724575 Polish. No abstract available.
-
[Current status of the problem of disseminated sclerosis].Klin Med (Mosk). 1985 Sep;63(9):12-9. Klin Med (Mosk). 1985. PMID: 2415750 Review. Russian. No abstract available.
-
[Immunosuppressive treatment im multiple sclerosis].Fortschr Med. 1980 Oct 2;98(37):1431-6. Fortschr Med. 1980. PMID: 6253370 Review. German.
Cited by
-
Immune-cell crosstalk in multiple sclerosis.Nature. 2018 Nov;563(7730):194-195. doi: 10.1038/d41586-018-07063-z. Nature. 2018. PMID: 30390068 No abstract available.
-
Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173. J Neurol. 1980. PMID: 6157007 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources